NO20065469L - Behandling av infeksjonssykdommer. - Google Patents

Behandling av infeksjonssykdommer.

Info

Publication number
NO20065469L
NO20065469L NO20065469A NO20065469A NO20065469L NO 20065469 L NO20065469 L NO 20065469L NO 20065469 A NO20065469 A NO 20065469A NO 20065469 A NO20065469 A NO 20065469A NO 20065469 L NO20065469 L NO 20065469L
Authority
NO
Norway
Prior art keywords
treatment
infectious diseases
derivatives
chemosensitizing
compounds
Prior art date
Application number
NO20065469A
Other languages
English (en)
Inventor
Birgit Kjaeldgaard Giwercman
Original Assignee
Bkg Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bkg Pharma Aps filed Critical Bkg Pharma Aps
Publication of NO20065469L publication Critical patent/NO20065469L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Den foreliggende oppfinnelsen er rettet mot anvendelsen av kjemosensitiverende forbindelser, særlig tioksantenderivater og fenotiazinderivater, for behandling av infeksjonssykdommer i kombinasjon med et antiinfektivt middel. Oppfinnelsen angår videre sammensetninger som omfatter nevnte kjemosensitiverende forbindelser og anti-infektive midler.
NO20065469A 2004-04-30 2006-11-28 Behandling av infeksjonssykdommer. NO20065469L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400680 2004-04-30
DKPA200401716 2004-11-08
PCT/DK2005/000294 WO2005105145A1 (en) 2004-04-30 2005-04-29 Treatment of infectious diseases

Publications (1)

Publication Number Publication Date
NO20065469L true NO20065469L (no) 2007-01-24

Family

ID=34965444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065469A NO20065469L (no) 2004-04-30 2006-11-28 Behandling av infeksjonssykdommer.

Country Status (13)

Country Link
US (1) US20080318970A1 (no)
EP (2) EP1744781B1 (no)
JP (2) JP5026255B2 (no)
CN (1) CN1976723B (no)
AU (1) AU2005237208B2 (no)
CA (1) CA2564684C (no)
DK (1) DK1744781T3 (no)
EA (1) EA016803B1 (no)
ES (1) ES2390226T3 (no)
HK (1) HK1104460A1 (no)
MX (1) MXPA06012566A (no)
NO (1) NO20065469L (no)
WO (1) WO2005105145A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080398A1 (en) * 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
EP2246349A1 (en) 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
US9504692B2 (en) 2011-08-02 2016-11-29 Helmholtz Zentrum Munchen, Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Selective inhibition of MALT1 protease by phenothiazine derivatives
WO2013043744A2 (en) 2011-09-21 2013-03-28 Inception 1, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
AU2012316085A1 (en) * 2011-09-29 2014-05-22 Emory University Sphingosine analogs, compositions, and methods related thereto
WO2014080378A1 (en) * 2012-11-26 2014-05-30 University Of Cape Town Phenothiazine derivatives and their use against tuberculosis
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
KR20190025920A (ko) 2016-06-23 2019-03-12 바이오이믹스 아베 항-감염 헤테로사이클릭 화합물 및 이의 용도
WO2018070874A1 (en) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Means and methods for reducing or avoiding antibiotic resistance and spread of virulence in human pathogens
US20220313656A1 (en) * 2019-04-24 2022-10-06 Københavns Universitet New class of antibiotics having low mic-values towards different strains of bacteria
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (no) 1958-05-29
DE1210890B (de) 1960-03-07 1966-02-17 Smith & Kline & French Lab Verfahren zur Herstellung von Trifluormethyl-xanthen- oder thioxanthenderivaten
HU190078B (en) * 1983-03-25 1986-08-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing new antibacterial pharmaceutical composition and/or food-premix
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6989396B2 (en) * 2001-04-12 2006-01-24 The Board Of Trustees Of The University Of Illinois Tropane alkaloid multidrug resistance inhibitors from Erythroxylum pervillei and use of the same
WO2002089810A1 (en) * 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
RU2330642C2 (ru) 2001-07-06 2008-08-10 Лайфсайкл Фарма А/С Регулируемая агломерация
AU2003222197A1 (en) * 2002-01-16 2003-09-02 The Regents Of The University Of California Inhibition of rna function
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
US8623864B2 (en) * 2003-11-13 2014-01-07 Noa Sic Aps Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance

Also Published As

Publication number Publication date
ES2390226T3 (es) 2012-11-07
AU2005237208B2 (en) 2009-12-03
JP2007535510A (ja) 2007-12-06
EP2260870A2 (en) 2010-12-15
CN1976723A (zh) 2007-06-06
EA016803B1 (ru) 2012-07-30
MXPA06012566A (es) 2007-05-09
WO2005105145A1 (en) 2005-11-10
EP1744781A1 (en) 2007-01-24
JP2012082219A (ja) 2012-04-26
EA200601889A1 (ru) 2007-06-29
AU2005237208A1 (en) 2005-11-10
DK1744781T3 (da) 2012-10-15
EP2260870A3 (en) 2012-12-26
CA2564684A1 (en) 2005-11-10
JP5026255B2 (ja) 2012-09-12
HK1104460A1 (en) 2008-01-18
CA2564684C (en) 2010-10-26
EP1744781B1 (en) 2012-07-04
CN1976723B (zh) 2010-12-29
US20080318970A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
NO20065469L (no) Behandling av infeksjonssykdommer.
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
BRPI0507198A (pt) derivados de bisariluréia
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200802213A1 (ru) Способы лечения заболеваний крови
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
EA200801997A1 (ru) Новые соединения
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
EA200870086A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства
TW200633995A (en) Andrographolide derivatives to treat viral infections
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
ME00979B (me) DERIVATI INDOL-2-ONA, DISUPSTITUISANI NA 3-POZICIJI, NJIHOVO DOBIJANJE l PRIMJENA U TERAPIJI
CY1111778T1 (el) Παραγωγα θειοξανθενιου ως μοναδικοι αντιμολυσματικοι παραγοντες για χρηση στην αντιμετωπιση των μολυσματικων ασθενειων
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE508125T1 (de) Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application